Laird Norton Wetherby Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.9M | Buy |
44,133
+1,171
| +3% | +$133K | 0.2% | 80 |
|
|
2025
Q2 | $4.76M | Buy |
+42,962
| New | +$4.57M | 0.21% | 78 |
|
|
2024
Q4 | $3.71M | Sell |
40,119
-533
| -1% | -$48K | 0.18% | 100 |
|
|
2024
Q3 | $3.41M | Buy |
40,652
+38
| +0.1% | +$2.9K | 0.16% | 115 |
|
|
2024
Q2 | $2.79M | Sell |
40,614
-13,505
| -25% | -$901K | 0.13% | 149 |
|
|
2024
Q1 | $3.96M | Buy |
54,119
+7,850
| +17% | +$604K | 0.19% | 98 |
|
|
2023
Q4 | $3.75M | Buy |
46,269
+852
| +2% | +$66.3K | 0.2% | 94 |
|
|
2023
Q3 | $3.4M | Sell |
45,417
-1,118
| -2% | -$86K | 0.19% | 96 |
|
|
2023
Q2 | $3.59M | Buy |
46,535
+1,325
| +3% | +$106K | 0.19% | 94 |
|
|
2023
Q1 | $3.75M | Sell |
45,210
-197
| -0.4% | -$16.3K | 0.22% | 86 |
|
|
2022
Q4 | $3.9M | Sell |
45,407
-3,004
| -6% | -$238K | 0.25% | 77 |
|
|
2022
Q3 | $2.99M | Buy |
48,411
+4,781
| +11% | +$301K | 0.21% | 92 |
|
|
2022
Q2 | $2.7M | Buy |
43,630
+4,697
| +12% | +$291K | 0.18% | 103 |
|
|
2022
Q1 | $2.31M | Sell |
38,933
-3,081
| -7% | -$197K | 0.13% | 139 |
|
|
2021
Q4 | $3.05M | Buy |
42,014
+452
| +1% | +$31.1K | 0.17% | 108 |
|
|
2021
Q3 | $2.9M | Sell |
41,562
-7,036
| -14% | -$494K | 0.18% | 105 |
|
|
2021
Q2 | $3.35M | Buy |
48,598
+15,034
| +45% | +$1M | 0.2% | 92 |
|
|
2021
Q1 | $2.17M | Sell |
33,564
-22,098
| -40% | -$1.42M | 0.17% | 123 |
|
|
2020
Q4 | $3.24M | Buy |
55,662
+11,235
| +25% | +$678K | 0.22% | 83 |
|
|
2020
Q3 | $2.81M | Sell |
44,427
-3,689
| -8% | -$256K | 0.25% | 82 |
|
|
2020
Q2 | $3.7M | Buy |
48,116
+1,220
| +3% | +$93.5K | 0.35% | 54 |
|
|
2020
Q1 | $3.51M | Buy |
46,896
+6,588
| +16% | +$455K | 0.39% | 46 |
|
|
2019
Q4 | $2.62M | Sell |
40,308
-1,372
| -3% | -$89.3K | 0.26% | 86 |
|
|
2019
Q3 | $2.64M | Sell |
41,680
-1,969
| -5% | -$129K | 0.28% | 80 |
|
|
2019
Q2 | $2.95M | Buy |
43,649
+4,986
| +13% | +$328K | 0.32% | 68 |
|
|
2019
Q1 | $2.51M | Buy |
38,663
+717
| +2% | +$47.7K | 0.31% | 69 |
|
|
2018
Q4 | $2.37M | Sell |
37,946
-802
| -2% | -$56.1K | 0.34% | 65 |
|
|
2018
Q3 | $2.99M | Sell |
38,748
-95
| -0.2% | -$7.17K | 0.37% | 60 |
|
|
2018
Q2 | $2.75M | Buy |
38,843
+215
| +0.6% | +$15.2K | 0.37% | 58 |
|
|
2018
Q1 | $2.91M | Sell |
38,628
-543
| -1% | -$43.2K | 0.4% | 49 |
|
|
2017
Q4 | $2.81M | Sell |
39,171
-3,658
| -9% | -$278K | 0.39% | 53 |
|
|
2017
Q3 | $3.47M | Buy |
42,829
+1,573
| +4% | +$120K | 0.52% | 36 |
|
|
2017
Q2 | $2.92M | Buy |
41,256
+5,318
| +15% | +$354K | 0.5% | 39 |
|
|
2017
Q1 | $2.44M | Sell |
35,938
-3,478
| -9% | -$245K | 0.44% | 45 |
|
|
2016
Q4 | $2.82M | Sell |
39,416
-1,389
| -3% | -$103K | 0.55% | 33 |
|
|
2016
Q3 | $3.23M | Sell |
40,805
-2,463
| -6% | -$200K | 0.65% | 26 |
|
|
2016
Q2 | $3.61M | Buy |
43,268
+1,596
| +4% | +$142K | 0.8% | 22 |
|
|
2016
Q1 | $3.83M | Buy |
41,672
+2,349
| +6% | +$212K | 0.9% | 17 |
|
|
2015
Q4 | $3.98M | Sell |
39,323
-1,153
| -3% | -$120K | 0.95% | 16 |
|
|
2015
Q3 | $3.97M | Sell |
40,476
-576
| -1% | -$64K | 1.02% | 16 |
|
|
2015
Q2 | $4.81M | Buy |
41,052
+1,692
| +4% | +$185K | 1.16% | 12 |
|
|
2015
Q1 | $3.86M | Buy |
39,360
+751
| +2% | +$76.3K | 0.94% | 18 |
|
|
2014
Q4 | $3.64M | Buy |
38,609
+412
| +1% | +$42.6K | 0.92% | 17 |
|
|
2014
Q3 | $4.07M | Sell |
38,197
-3,156
| -8% | -$309K | 1.13% | 14 |
|
|
2014
Q2 | $3.43M | Buy |
41,353
+2,040
| +5% | +$159K | 0.97% | 17 |
|
|
2014
Q1 | $2.79M | Buy |
39,313
+18
| +0% | +$1.41K | 0.8% | 21 |
|
|
2013
Q4 | $2.95M | Buy |
39,295
+526
| +1% | +$36.6K | 0.84% | 21 |
|
|
2013
Q3 | $2.44M | Buy |
38,769
+1,600
| +4% | +$95.6K | 0.76% | 25 |
|
|
2013
Q2 | $1.91M | Buy |
+37,169
| New | +$1.94M | 0.66% | 30 |
|
Other funds holding GILD
Laird Norton Wetherby Wealth Management's GILD Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management increased its Gilead Sciences (GILD) stake by 2.7% in Q3 2025, buying an estimated $133K and bringing the position to 44,133 shares worth $4.9M. The position accounts for 0.2% of the portfolio, ranked #80.
Laird Norton Wetherby Wealth Management first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 44,133 shares of Gilead Sciences worth $4.9M as of Q3 2025.
- Laird Norton Wetherby Wealth Management bought 1,171 Gilead Sciences shares in Q3 2025, an estimated $133K.
- Gilead Sciences made up 0.2% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #80 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.